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SES Superior to Angioplasty for In-Stent Restenosis
Although drug-eluting stents are clearly superior to bare-metal stents for de novolesions, the preferred strategy for in-stent restenosis (ISR) is less clear. Alfonso and
colleagues randomized 150 patients with ISR to either balloon angioplasty (BA) or
angioplasty plus stenting with a sirolimus-eluting stent (SES). At nine-month angio-
graphic follow-up, the binary restenosis rate was nearly four times lower and was less
diffuse for SES. This study adds further evidence that the preferred strategy for ISR is
a drug-eluting stent. See page 2152.
Interventional Cardiology
Stents for Stenoses <50%?
Whether to treat borderline stenoses relies on a calculation of the risks andbenefits. As the safety of stentinghas improved and the in-stent restenosis (ISR)
rate with drug-eluting stents (DES) goes down, a lower threshold for interventionmay
be appropriate. Moses and colleagues compiled data from four trials in which the
inclusion criteria specified a visually assessed diameter stenosis 50%. The one-year
target lesion revascularization for these lesions was 20% with bare-metal stents, but
only 1% for DES. Similarly, the binary restenosis rate was reduced from 32% to 2%.
These low rates of adverse events suggest that the threshold for intervention on
borderline lesions may be lower in the era of DES. See page 2164.
Page 2197
Vulnerable Plaque
Plaque Color and the Subsequent Risk of Plaque Rupture
Ohtani and colleagues report on the long-term follow-up of over 500patientswhohad been previously studied with angioscopy. For each angioscopy, the number
of yellow lesions in the artery of interest and the intensity of the yellow color were
recorded. The 7% of subjects who had a subsequent acute coronary syndrome (ACS)
were then compared to the others. The number of yellow lesions in patients with
subsequent ACSwas 3.1 versus 1.8 in patients with no future events. Patients with 5 or
more yellow lesionswere 4 timesmore likely to have a subsequentACS than thosewith
0 or 1 yellow lesion. This study suggests that the number of yellow lesions is predictive
of future plaque rupture. See page 2194. See figure.
(continued) A-47Vulnerable Plaque
Pregnancy-Associated Plasma Protein A May Induce Plaque Rupture
Pregnancy-associated plasma protein A (PAPP-A) is a metalloproteinase that isconstitutively expressed in both men and women, with increased levels during
pregnancy. Previous studies have found that it is a negative prognostic indicator in
patients with acute coronary syndromes. Sangiorgi and colleagues studied tissue and
serum samples from patients undergoing carotid endarterectomies. Higher PAPP-A
serum levels were found in patients with vulnerable or ruptured plaques. Immunoflu-
orescence staining and quantitative analyses showed higher levels of PAPP-A in vul-
nerable or ruptured plaques; it appears to be produced bymacrophages within the cap
or shoulder of atherosclerotic lesions. This study adds further support to the hypothesis
that active inflammation leads to plaque rupture and that PAPP-Amight have a role in
destabilizing lesions. See page 2201.
Page 2226
Carotid and
Peripheral Atherosclerosis
Oxidized Phospholipids, Lp(a), and Atherosclerosis
Emerging evidence suggests that the amount of oxidized phospholipids (OxPL)present on apolipoprotein B-100 particles (apoB) may correlate with cardiovas-
cular risk. Tsimikas and colleagues studied the relationship between serum levels of
OxPL, lipoprotein (a) [Lp(a)], and several other putativemarkers of cardiovascular risk
in patients enrolled in a large prospective community cohort who underwent serial
ultrasound of their carotid and femoral arteries. The ratio of OxPL to apoB correlated
strongly with the level of Lp(a) and bothmeasures remained stable over time. Further-
more, both markers correlated strongly with the extent and progression of atheroscle-
rosis. The authors propose that Lp(a) serves as a sink for OxPL and that both may be
useful for cardiovascular risk stratification. See page 2219. See figure.
Page 2232
Valvular Heart Disease
Faster Progression of Aortic Stenosis in Patients With Metabolic Syndrome
Several lines of evidence suggest that the progression of aortic stenosis (AS) ismediated by inflammation and atherosclerosis. Briand and colleagues hypothe-
sized that patients with themetabolic syndrome (MS)would have faster rates of disease
progression than those without. They studied patients with at least moderate AS and
serial echocardiograms separated by at least six months. The rate of progression was
found to be influenced by the severity at baseline,male gender, and presence or absence
of MS. The rate of progression in patients with MS was0.14 cm2/year versus only
0.08 cm2/year in patients withoutMS. This study supports the hypothesis that AS is
an active process mediated by many of the same factors that influence the progression
of atherosclerosis. See page 2229. See figure.
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Dyssynchrony
Assessing Ventricular Dyssynchrony During Exercise
Asynchronousmyocardial contraction impairs ventricular function. Although dys-synchrony at rest can be measured and ameliorated with cardiac resynchroniza-
tion therapy, little is known about dyssynchrony during exercise. Lafitte and colleagues
used tissue Doppler to measure interventricular and intraventricular dyssynchrony
during supine bicycle exercise. In patients with normal left ventricular function,
exercise did not modify the extent of intraventricular dyssynchrony. In heart failure
patients, intraventricular dyssynchrony significantly increased in about one-third of
patients, remained stable in about one-third, and actually decreased in the final
one-third. This study has two novel findings. Ventricular dyssynchrony can be assessed
during dynamic exercise and dyssynchrony during exercisemay differ from that at rest.
See page 2253. See figure.
Page 2279
Pediatric and
Adolescent Heart Disease
Remote Ischemic Preconditioning Beneficial for Cardiac Surgery
Ischemic preconditioning is a well-validated but poorly understood phenomenonwhereby transient ischemia produces factors that reduce the damage caused by
subsequent ischemia. Because these factors appear to be soluble, it may be possible to
provide protection by inducing ischemia in a remote organ. Cheung and colleagues
have developed a protocol where they induce transient ischemia in the leg by inflating
a blood pressure cuff to higher than the systolic pressure. They randomized children
undergoing cardiac surgery to either preconditioning or shamprocedure. Patients who
had undergone ischemic preconditioning had lower levels of serum troponin post-
operatively and decreased need for inotropic support. The authors call for larger studies
and studies in adults to see if this simple procedure can indeed reduce the myocardial
injury seen after cardiac surgery. See page 2277. See figure.
